Product Information
TEMAZEPAM 30 MG CAPSULE is a generic product labeled by SpecGx LLC, priced at $0.0908 per EA under NDC 00406996201. Its NADAC has been published 302 times since Nov 11, 2020.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the temazepam market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
30 mg/1
Manufacturer
SpecGx LLCNDC
00406996201
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
TEMAZEPAMApproval Type
New Drug (NDA)
FDA Application
NDA018163FDA Approved
Before 1982
TE Code
AB
On Market Since
2/23/2010
Pharmacological Classes
Price Statistics
The NADAC for TEMAZEPAM 30 MG CAPSULE has been published 302 times since Nov 11, 2020, and over the history we have for it it has declined 10.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0908 per EA |
|---|---|
| All-time high | $0.1075 (Sep 15, 2021) |
| All-time low | $0.0726 (Nov 20, 2024) |
| 52-week high | $0.0926 |
| 52-week low | $0.0894 |
| Median price | $0.0928 |
| Average price | $0.0933 |
| Largest weekly change | -20.4% (Nov 20, 2024) |
| Weeks tracked | 302 |
| Tracking since | Nov 11, 2020 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TEMAZEPAM 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TEMAZEPAM 30 MG CAPSULE, manufactured by SpecGx LLC, is $0.0908 per EA (NDC 00406996201), effective Aug 19, 2026.
How has the price of TEMAZEPAM 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TEMAZEPAM 30 MG CAPSULE has declined 10.7%. It has been tracked across 302 weekly CMS publications since Nov 11, 2020.
What are the highest and lowest recorded NADAC prices for TEMAZEPAM 30 MG CAPSULE?
Since Nov 11, 2020, the NADAC for TEMAZEPAM 30 MG CAPSULE has ranged from a low of $0.0726 (Nov 20, 2024) to a high of $0.1075 (Sep 15, 2021), with a median of $0.0928 per EA.
Are there cheaper alternatives to TEMAZEPAM 30 MG CAPSULE?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TEMAZEPAM 30 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures TEMAZEPAM 30 MG CAPSULE?
TEMAZEPAM 30 MG CAPSULE (NDC 00406996201) is labeled by SpecGx LLC, and CMS classifies it as a generic product.